Which has grown faster, MRNA or VTRS?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus VTRS at 1.14%.

Does MRNA or VTRS pay a bigger dividend?

VTRS pays a dividend (2.78% yield) while MRNA does not currently pay one.

Which has been the better investment, MRNA or VTRS?

Over the past 5-year, VTRS delivered the higher annualized total return — MRNA at -29.07% versus VTRS at -7.45%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Viatris Inc. (VTRS)

VTRS leads on 7 of 9 compared metrics.

A side-by-side comparison of Moderna, Inc. and Viatris Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 23, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

MRNA

Moderna, Inc.

$22.62B

$57.02HealthcareDelayed quote: Jul 23, 2026, 4:00 PM EDT

VTRS

Viatris Inc.

$20.12B

$17.28HealthcareAt close: Jul 23, 2026, 4:00 PM ET

Total return — MRNA vs VTRS

growth of $100 · dividends reinvested · last 8y

MRNA +212.2%VTRS -34.8%MRNA compounded faster

MRNA VTRS

MRNA vs VTRS: by the numbers

•MRNA is the larger company ($22.62B vs $20.12B market cap).
•Both run net losses; VTRS's is the smaller (-2.04% vs -143.55% net margin).
•MRNA grew revenue faster over the past five years (19.33% vs 1.14% CAGR).
•VTRS pays a dividend (2.78% yield) while MRNA does not currently pay one.

Which is better, MRNA or VTRS?

Metric tally: MRNA 2 · VTRS 7

It depends on what you're optimizing for:

GrowthMRNA(faster 5Y revenue CAGR)

QualityVTRS(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	VTRS
Forward P/E	—	7.05
P/S ratio	10.31	1.39●
P/B ratio	3.10	1.39●
EV / EBITDA	—	11.14
FCF yield	—	8.42%

Profitability

Metric	MRNA	VTRS
Gross margin	55.35%●	34.40%
Operating margin	-153.35%	-18.62%●
Net margin	-143.55%	-2.04%●
ROE	-43.12%	-2.02%●
ROIC	-29.70%	-7.95%●

Dividends

Metric	MRNA	VTRS
Dividend yield	—	2.78%

Growth (annualized)

Metric	MRNA	VTRS
Revenue CAGR (5Y)	19.33%●	1.14%
EPS CAGR (5Y)	—	-41.91%
FCF CAGR (5Y)	—	2.28%
Total return CAGR (5Y)	-29.07%	8.90%●

Frequently asked

Which is better, MRNA or VTRS?: It depends on your goal. growth: MRNA (faster 5Y revenue CAGR); quality: VTRS (higher ROIC). Across all compared metrics, VTRS leads 7 to 2.
Which has grown faster, MRNA or VTRS?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus VTRS at 1.14%.
Does MRNA or VTRS pay a bigger dividend?: VTRS pays a dividend (2.78% yield) while MRNA does not currently pay one.
Which has been the better investment, MRNA or VTRS?: Over the past 5-year, VTRS delivered the higher annualized total return — MRNA at -29.07% versus VTRS at -7.45%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full VTRS analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Viatris P/E ratio Moderna dividend yield Viatris dividend yield Moderna ROE Viatris ROE Moderna operating margin Viatris operating margin Moderna revenue growth Viatris revenue growth Moderna free cash flow Viatris free cash flow

Moderna & Viatris appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 23, 2026.